These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
459 related items for PubMed ID: 26488563
1. Polymyxin B versus colistin: an update. Cai Y, Lee W, Kwa AL. Expert Rev Anti Infect Ther; 2015; 13(12):1481-97. PubMed ID: 26488563 [Abstract] [Full Text] [Related]
2. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics. Kassamali Z, Jain R, Danziger LH. Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655 [Abstract] [Full Text] [Related]
3. To B or not to B, that is the question: is it time to replace colistin with polymyxin B? Kassamali Z, Danziger L. Pharmacotherapy; 2015 Jan; 35(1):17-21. PubMed ID: 25346395 [Abstract] [Full Text] [Related]
6. Polymyxin B: similarities to and differences from colistin (polymyxin E). Kwa A, Kasiakou SK, Tam VH, Falagas ME. Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915 [Abstract] [Full Text] [Related]
7. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Evans ME, Feola DJ, Rapp RP. Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501 [Abstract] [Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? Bergen PJ, Landersdorfer CB, Zhang J, Zhao M, Lee HJ, Nation RL, Li J. Diagn Microbiol Infect Dis; 2012 Nov; 74(3):213-23. PubMed ID: 22959816 [Abstract] [Full Text] [Related]
10. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B? Zavascki AP, Nation RL. Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859 [Abstract] [Full Text] [Related]
15. Colistin: an update on the antibiotic of the 21st century. Biswas S, Brunel JM, Dubus JC, Reynaud-Gaubert M, Rolain JM. Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331 [Abstract] [Full Text] [Related]
16. Bioanalysis and Stability of Polymyxins. Milne RW. Adv Exp Med Biol; 2019 Aug; 1145():73-87. PubMed ID: 31364072 [Abstract] [Full Text] [Related]
17. Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use. Nation RL, Forrest A. Adv Exp Med Biol; 2019 Aug; 1145():219-249. PubMed ID: 31364081 [Abstract] [Full Text] [Related]
18. Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models. Landersdorfer CB, Wang J, Wirth V, Chen K, Kaye KS, Tsuji BT, Li J, Nation RL. J Antimicrob Chemother; 2018 Feb 01; 73(2):462-468. PubMed ID: 29149294 [Abstract] [Full Text] [Related]
20. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD. Lancet Infect Dis; 2015 Feb 01; 15(2):225-34. PubMed ID: 25459221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]